Bridgeway Capital Management, LLC Pacira Bio Sciences, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.24 Billion
- Q4 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 358,785 shares of PCRX stock, worth $9.49 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
358,785
Previous 347,636
3.21%
Holding current value
$9.49 Million
Previous $5.24 Million
29.11%
% of portfolio
0.16%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding PCRX
# of Institutions
259Shares Held
49.7MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$212 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$139 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$86.3 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$59.7 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$52.7 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.21B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...